Allergan PLC | Key People and Executives
Brenton L. Saunders
Chairman, President & Chief Executive Officer
Michael E. Greenberg
Director
Carol Anthony Davidson
Director
Thomas C. Freyman
Director
Joseph H. Boccuzi
Independent Director
Adriane M. Brown
Independent Director
Peter John McDonnell
Independent Director
Nesli Basgoz
Independent Director
Fred G. Weiss
Independent Director
Catherine M. Klema
Independent Director
Christopher W. Bodine
Independent Director
Christopher J. Coughlin
Lead Independent Director
Brenton L. Saunders
Chairman, President & Chief Executive Officer
Wayne R. Swanton
Executive Vice President-Global Operations
Matthew M. Walsh
Chief Financial Officer & Executive Vice President
Charles Hugh-Jones
Chief Medical Officer
C. David Nicholson
Chief Research & Development Officer
Armin Szegedi
VP-Clinical Development/CNS
John Alexander Kelly
Chief Communications Officer
William J. Meury
Chief Commercial Officer
Jonathon Kellerman
Global Chief Compliance Officer & Executive VP
Michael E. Greenberg
Director
Carol Anthony Davidson
Director
Thomas C. Freyman
Director
James C. Darecca
Chief Accounting Officer
Daphne Karydas
Senior VP-Investor Relations & Strategy
Karina Calzadilla
Investor Relations Contact
Karen L. Ling
Chief Human Resources Officer
Ambrose Robert Douglas Bailey
Secretary, Chief Legal Officer & Executive VP
Joseph H. Boccuzi
Independent Director
Adriane M. Brown
Independent Director
Peter John McDonnell
Independent Director
Nesli Basgoz
Independent Director
Fred G. Weiss
Independent Director
Catherine M. Klema
Independent Director
Christopher W. Bodine
Independent Director
Christopher J. Coughlin
Lead Independent Director
| Address |
Clonshaugh Business & Tech. Park
Dublin Dublin D17 E400
Ireland
|
|
Employees
|
- |
| Website |
http://www.allergan.com |
| Updated |
07/08/2019 |
| Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. |
